|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
���� |
|
����,���� |
|
����Ǵ�,ϵͳ�� |
| ��������������� | |
|
Ԭ���� |
|
¬��÷ |
|
����� |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
����С�忹����ϵͳ�Ժ���Ǵ��е�����
Ԭ����, ¬��÷, �����
ɽ��ʡƤ����ҽԺ, ����250022
�Ǵ��п�ds-DNA���塢���鵰�������С�������Կ���ͬ���ڴ�Ŀ���С�忹�����,��ds-DNA���塢��С�������Կ���ͺ�С��-����С�忹�����߸�������ϵͳ�Ժ���Ǵ��IJ�������������Ҫ���á�����С��IgG�����DZȿ�ds-DNA��������е�ϵͳ�Ժ���Ǵ�ָ��,����С��IgG�������ϵͳ�Ժ���Ǵ���ӲƤ������Ͻ����֯���г���,��ˮƽ�Ŀ���С��IgG���弸���ǽ���ϵͳ�Ժ���Ǵ��г���,����С��IgG3������ϵͳ�Ժ���Ǵ������ָ���к�ǿ����ϵ��
[2] Rekvig OP, Moens U, Sundsfjord A, et al. Experimental expression in mice and spontaneous expression in human SLE of polyomavirus Tantigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors. J Clin Invest, 1997, 99:2045-2054.
[3] Bruns A, Blass S, Hausdorf G, et al. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum,2000, 43:2307-2315.
[4] Chabre H, Amoura Z, Piette JC, et al. Presence of nucleosome-re-strieted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum, 1995, 38:1485-1491.
[5] Burlingame RW, Rubin RL. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J Immunol Methods, 1990,134:187-199.
[6] Franek F, Dolnikova J. Nucleosomes occurring in protein-free hybridoma cell culture. Evidence for programmed cell death. FEBS Lett,1991,284:285-287.
[7] Kramers C, Hylkema MN, van Bruggen MC, et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest, 1994, 94:568-577.
[8] Grootscholten C, van Bruggen MC, van der Pijl JW, et al. Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis. Arthritis Rheum, 2003,48:1355-1362.
[9] Amoura Z, Koutouzov S, Chabre H, et al. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases:antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum,2000, 43:76-84.
[10] Cairns AP, McMillan SA, Crockard AD, et al. Antinucleosome antibodies in the diagnosis of systemic lupus erythematosus. Ann Rheum Dis, 2003, 62:272-273.
[11] Simon JA, Cabiedes J, Ortiz E, et al. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology (Oxford), 2004, 43:220-224.
[12] Min DJ, Kim SJ, Park SH, et al. Anti-nucleosome antibody:significance in lupus patients lacking anti-double-stranded DNA antibody.Clin Exp Rheumatol, 2002, 20:13-18.
[13] Horak P, Scudla V, Hermanovo Z, et al. Clinical utility of selected disease activity markers in patients with systemic lupus erythematosus.Clin Rheumatol, 2001,20:337-344.
[14] Kiss E, Lakos G, Nemeth J, et al. Significance of anti-nucleosome (anti-chromatin) auto-antibodies in systemic lupus erythematosus.Orv Hetil, 2001, 142:1731-1736.
[15] Benucci M, Gobbi FL, Del Rosso A,et al. Disease activity and antinucleosome antibodies in systemic lupus erythematosus. Scand J Rheumatol, 2003, 32:42-45.
[16] Kaliyaperumal A, Michaels MA, Datta SK. Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides:tolerance spreading impairs pathogenic function of autoimmune T and B cells. J Immunol, 1999, 162(10):5775-5783.